The Wall Street Journal @WSJ
Doctors in some countries, such as Australia and Japan, are prescribing Merck’s less-effective Covid-19 antiviral pill more frequently than Pfizer’s Paxlovid, citing a risk of drug interactions https://t.co/KcVgQHuoGy — PolitiTweet.org